Literature DB >> 1579714

Chemical inactivation of the Kveim reagent.

D J Lyons1, S Donald, D N Mitchell, G L Asherson.   

Abstract

In an attempt to identify the nature of the active principle, Kveim reagent was exposed to chemical fractionating agents. Thirty-one patients with sarcoidosis underwent simultaneous intradermal injection with fractionated and unfractionated Kveim material. Kveim reagent was stable in the presence of DNAse, RNAse, pronase, 95% phenol, neutral detergent, and to lipid extraction with chloroform-methanol. Kveim reagent was also stable in the presence of both 8 M urea (8MU) and 2-mercaptoethanol (2ME) when used alone. When both these agents were used together, Kveim reagent was inactivated. Fourteen patients had a positive test to unfractionated Kveim reagent; of these, only 2 gave a positive response to material fractionated by exposure to 8MU and 2ME. Simultaneous exposure to 8MU and 2ME was more likely to inactivate Kveim reagent (10/10 tests) than sequential exposure to 8MU and 2ME (2/4 tests). Chemical analysis of the fractionated material showed that it retained granuloma-generating activity despite the lack of carbohydrates. Protein loss in terms of total and relative amino acid composition was progressive and non-specific throughout processing. These results are consistent with a protein-active principle which is dependent on three-dimensional structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579714     DOI: 10.1159/000196019

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

Review 1.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

Review 2.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

Review 3.  Potential etiologic agents in sarcoidosis.

Authors:  David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

4.  Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Authors:  Edward S Chen; Zhimin Song; Matthew H Willett; Shannon Heine; Rex C Yung; Mark C Liu; Steve D Groshong; Ying Zhang; Rubin M Tuder; David R Moller
Journal:  Am J Respir Crit Care Med       Date:  2009-11-12       Impact factor: 21.405

5.  Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.

Authors:  Christian Eberhardt; Muhunthan Thillai; Robert Parker; Nazneen Siddiqui; Lee Potiphar; Rob Goldin; John F Timms; Athol U Wells; Onn M Kon; Melissa Wickremasinghe; Donald Mitchell; Mark E Weeks; Ajit Lalvani
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

6.  Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Authors:  Zhimin Song; Lisa Marzilli; Brian M Greenlee; Edward S Chen; Richard F Silver; Frederic B Askin; Alvin S Teirstein; Ying Zhang; Robert J Cotter; David R Moller
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.